Connection

David Jollow to Male

Back to Details
This is a "connection" page, showing publications David Jollow has written about Male.
David Jollow
Connection Strength
0.237
Male
  1. Role of oxidant stress in lawsone-induced hemolytic anemia. Toxicol Sci. 2004 Dec; 82(2):647-55.
    View in: PubMed
    Score: 0.013
  2. Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice. Malar J. 2022 Feb 05; 21(1):33.
    View in: PubMed
    Score: 0.011
  3. Favism: effect of divicine on rat erythrocyte sulfhydryl status, hexose monophosphate shunt activity, morphology, and membrane skeletal proteins. Toxicol Sci. 2001 Aug; 62(2):353-9.
    View in: PubMed
    Score: 0.010
  4. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001 May; 297(2):509-15.
    View in: PubMed
    Score: 0.010
  5. Favism: divicine hemotoxicity in the rat. Toxicol Sci. 1999 Oct; 51(2):310-6.
    View in: PubMed
    Score: 0.009
  6. Role of lipid peroxidation in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther. 1998 Dec; 287(3):868-76.
    View in: PubMed
    Score: 0.009
  7. Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine. Free Radic Biol Med. 1997; 22(7):1183-93.
    View in: PubMed
    Score: 0.007
  8. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes. J Pharmacol Exp Ther. 1995 Jul; 274(1):540-7.
    View in: PubMed
    Score: 0.007
  9. Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol. 1995 Jun; 88(3):327-38.
    View in: PubMed
    Score: 0.007
  10. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 1995 Apr; 21(4):1045-50.
    View in: PubMed
    Score: 0.007
  11. Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamine. Free Radic Biol Med. 1995 Feb; 18(2):279-85.
    View in: PubMed
    Score: 0.007
  12. Chemical analysis and hemolytic activity of the fava bean aglycon divicine. Chem Res Toxicol. 1993 Jul-Aug; 6(4):439-44.
    View in: PubMed
    Score: 0.006
  13. Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol Appl Pharmacol. 1992 Aug; 115(2):234-40.
    View in: PubMed
    Score: 0.006
  14. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol. 1991 Oct; 111(1):1-12.
    View in: PubMed
    Score: 0.005
  15. Role of metabolites in propanil-induced hemolytic anemia. Toxicol Appl Pharmacol. 1991 Aug; 110(1):70-8.
    View in: PubMed
    Score: 0.005
  16. Arylamine-induced hemolytic anemia: electron spin resonance spectrometry studies. Adv Exp Med Biol. 1991; 283:253-5.
    View in: PubMed
    Score: 0.005
  17. Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia. Adv Exp Med Biol. 1991; 283:343-5.
    View in: PubMed
    Score: 0.005
  18. Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. Toxicol Appl Pharmacol. 1990 Sep 01; 105(2):195-208.
    View in: PubMed
    Score: 0.005
  19. Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol. 1989 Nov; 101(2):356-69.
    View in: PubMed
    Score: 0.005
  20. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450. Biochem Pharmacol. 1989 Jun 15; 38(12):2027-38.
    View in: PubMed
    Score: 0.004
  21. Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol. 1989 Jan 15; 38(2):289-97.
    View in: PubMed
    Score: 0.004
  22. Mechanism of decreased acetaminophen glucuronidation in the fasted rat. Biochem Pharmacol. 1988 Mar 15; 37(6):1067-75.
    View in: PubMed
    Score: 0.004
  23. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther. 1988 Jan; 244(1):118-25.
    View in: PubMed
    Score: 0.004
  24. Contribution of aniline metabolites to aniline-induced methemoglobinemia. Mol Pharmacol. 1987 Sep; 32(3):423-31.
    View in: PubMed
    Score: 0.004
  25. Relationship between sulfotransferase activity and susceptibility to acetaminophen-induced liver necrosis in the hamster. Drug Metab Dispos. 1987 Mar-Apr; 15(2):143-50.
    View in: PubMed
    Score: 0.004
  26. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol. 1987 Feb 15; 36(4):427-33.
    View in: PubMed
    Score: 0.004
  27. Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab Dispos. 1986 Nov-Dec; 14(6):689-91.
    View in: PubMed
    Score: 0.004
  28. Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther. 1986 Sep; 238(3):1045-54.
    View in: PubMed
    Score: 0.004
  29. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42.
    View in: PubMed
    Score: 0.004
  30. Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection. Toxicol Appl Pharmacol. 1986 Mar 30; 83(1):115-25.
    View in: PubMed
    Score: 0.004
  31. Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem Pharmacol. 1986 Feb 15; 35(4):687-95.
    View in: PubMed
    Score: 0.004
  32. The mechanisms of cobalt chloride-induced protection against acetaminophen hepatotoxicity. Drug Metab Dispos. 1986 Jan-Feb; 14(1):25-33.
    View in: PubMed
    Score: 0.003
  33. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes. J Pharmacol Exp Ther. 2005 Dec; 315(3):980-6.
    View in: PubMed
    Score: 0.003
  34. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2005 Aug; 314(2):838-45.
    View in: PubMed
    Score: 0.003
  35. Role of UDPGA flux in acetaminophen clearance and hepatotoxicity. Xenobiotica. 1984 Jul; 14(7):553-9.
    View in: PubMed
    Score: 0.003
  36. Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology. 2004 May 03; 197(3):189-97.
    View in: PubMed
    Score: 0.003
  37. Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Drug Metab Dispos. 1984 May-Jun; 12(3):271-9.
    View in: PubMed
    Score: 0.003
  38. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2004 Apr; 309(1):79-85.
    View in: PubMed
    Score: 0.003
  39. Rapid and sensitive method for the microassay of nitrosobenzene plus phenylhydroxylamine in blood. J Chromatogr. 1983 Oct 14; 277:173-82.
    View in: PubMed
    Score: 0.003
  40. Mechanism of ketone-induced protection from acetaminophen hepatotoxicity in the rat. Drug Metab Dispos. 1983 Sep-Oct; 11(5):451-7.
    View in: PubMed
    Score: 0.003
  41. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology. J Pharmacol Exp Ther. 2002 Oct; 303(1):141-8.
    View in: PubMed
    Score: 0.003
  42. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 1982 Mar; 220(3):504-13.
    View in: PubMed
    Score: 0.003
  43. Acetaminophen overdosage. J S C Med Assoc. 1977 Nov; 73(11):474-80.
    View in: PubMed
    Score: 0.002
  44. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther. 1976 Oct; 199(1):41-52.
    View in: PubMed
    Score: 0.002
  45. N-hydroxylation of p-chloroacetanilde in hamsters. Biochem Pharmacol. 1976 Mar 01; 25(5):599-601.
    View in: PubMed
    Score: 0.002
  46. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest. 1975 Aug; 68(2):181-90.
    View in: PubMed
    Score: 0.002
  47. Hepatic necrosis caused by furosemide. Nature. 1974 Oct 11; 251(5475):508-11.
    View in: PubMed
    Score: 0.002
  48. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
    View in: PubMed
    Score: 0.002
  49. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct; 187(1):195-202.
    View in: PubMed
    Score: 0.001
  50. Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity. Biochem Pharmacol. 1993 Feb 09; 45(3):780-2.
    View in: PubMed
    Score: 0.001
  51. Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology. 1987 Sep-Oct; 7(5):825-30.
    View in: PubMed
    Score: 0.001
  52. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J Lab Clin Med. 1987 Jul; 110(1):83-90.
    View in: PubMed
    Score: 0.001
  53. CONVERSION OF STEARIC ACID INTO OLEIC ACID IN ADIPOSE TISSUE. Biochim Biophys Acta. 1964 Aug 05; 84:478-80.
    View in: PubMed
    Score: 0.001
  54. Vasopressin stimulates thromboxane synthesis in isolated hamster hepatocytes: relation to hepatocyte calcium content. Prostaglandins. 1983 Sep; 26(3):397-408.
    View in: PubMed
    Score: 0.001
  55. Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide. Pharmacology. 1976; 14(3):205-17.
    View in: PubMed
    Score: 0.000
  56. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974 Oct; 16(4):676-84.
    View in: PubMed
    Score: 0.000
  57. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974 Jun 01; 14(11):2099-109.
    View in: PubMed
    Score: 0.000
  58. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology. 1974; 12(3):129-43.
    View in: PubMed
    Score: 0.000
  59. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct; 187(1):203-10.
    View in: PubMed
    Score: 0.000
  60. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973 Oct; 187(1):185-94.
    View in: PubMed
    Score: 0.000
  61. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973 Oct; 187(1):211-7.
    View in: PubMed
    Score: 0.000
  62. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther. 1973 Oct; 187(1):218-27.
    View in: PubMed
    Score: 0.000
  63. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene. Mol Pharmacol. 1973 May; 9(3):398-404.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.